Engineers Gate Manager’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Engineers Gate Manager’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-483	Closed	-$3.25K	–	2391
2023 Q4	$3.25K	Hold	483	–	–	﹤0.01%	1933
2023 Q3	$4.42K	Buy	483 +37	+8%	+$744	﹤0.01%	1739
2023 Q2	$9.41K	Buy	+446	New	+$13.7K	﹤0.01%	1687
2023 Q1	–	Sell	-457	Closed	-$16.2K	–	2091
2022 Q4	$16.2K	Buy	+457	New	+$54.9K	﹤0.01%	1612
2021 Q2	–	Sell	-453	Closed	-$120K	–	2117
2021 Q1	$120K	Sell	453 -435	-49%	-$137K	0.01%	1688
2020 Q4	$328K	Buy	+888	New	+$255K	0.01%	1245
2020 Q3	–	Sell	-403	Closed	-$116K	–	2045
2020 Q2	$116K	Sell	403 -447	-53%	-$132K	0.01%	1562
2020 Q1	$173K	Buy	+850	New	+$271K	0.01%	1299

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

AWP

Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Engineers Gate Manager's EIGR Position: Q1 2024 in Review

Engineers Gate Manager sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 483 shares — an estimated $3.25K sold.

Engineers Gate Manager first reported a position in EIGR in Q1 2020 and held it in 8 quarters. The position peaked at $328K in Q4 2020. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

Engineers Gate Manager reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Engineers Gate Manager sold 483 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $3.25K.
Engineers Gate Manager first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2020 and held it in 8 quarters.
Engineers Gate Manager's Eiger BioPharmaceuticals, Inc. position peaked at $328K in Q4 2020.
24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.